+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Disease Testing Market Analysis & Forecast to 2024-2034

  • PDF Icon

    Report

  • 200 Pages
  • May 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 5968626
The global respiratory disease testing market accounted for USD 3.44 billion in 2023 and is expected to reach at USD 5.65 billion by 2034 with a CAGR of 4.62% during the forecast period 2024-2034. Rising prevalence of respiratory diseases, increasing air pollution levels, heightened transmission of infections such as tuberculosis & hospital-acquired infections, surge in technological advancements, growing funding from diverse organizations & governments for various projects, rising focus on the development of new testing methods by companies, increasing adoption of imaging technologies such as Computed Tomography (CT) for diagnosing COPD, and growing introduction of innovative respiratory disease testing products are some of the key factors boosting the market growth.

Growing introduction of novel respiratory disease testing products is predicted to boost the market growth during the forecast period. The respiratory system, crucial for human survival, serves the essential function of breathing and contributes significantly to maintaining the body's blood pH balance, eliminating harmful waste, and regulating temperature. Disruption of its normal functions occurs with respiratory diseases, often triggered by inhaling harmful substances, smoking, or unhealthy habits. For instance, in May 2022, UK's QuantuMDx Group Limited, known for its groundbreaking point-of-care diagnostic solutions, has introduced its latest offering, the Q-POC SARS-CoV-2, Flu A/B & RSV Assay, aimed at respiratory panel testing. This launch signifies the company's broadening of its multiplex capabilities and commitment to delivering swift point-of-care testing options to its clientele.

By product, imaging tests was the highest revenue-grossing segment in the global respiratory disease testing market in 2023 owing to the growing trend towards the utilization of Computed Tomography (CT) scans, X-rays, & other imaging techniques to enhance visualization & obtain clearer disease stage images, rise in chronic respiratory conditions, and increasing introduction of advanced medical devices. For instance, in December 2022, Canon Inc. has revealed the introduction of its CXDI-Elite series of wireless digital radiography (DR2) devices, featuring the CXDI-720C Wireless sensor unit, targeting markets beyond Japan. Additionally, respiratory measurement devices is predicted to grow at the fastest CAGR during the forecast period owing to the physicians increasingly favor rapid and precise diagnostic methods, leading to a preference for tests such as pulse oximeters, growing demand for respiratory measurement devices, known as respirometers, which encompass spirometers, capnography, pulse oximeters, and peak flowmeters.

By application, asthma was the highest revenue-grossing segment in the global respiratory disease testing market in 2023 owing to the increasing prevalence of asthma and surge in partnerships & collaborations among market players. For instance, in January 2022, Highmark Health and Bosch have formed a research collaboration aimed at investigating the application of cutting-edge sensor technology and artificial intelligence (AI) for the detection of pediatric pulmonary conditions such as asthma. This partnership extends the tradition of utilizing innovative approaches in healthcare. Additionally, lung cancer is predicted to grow at the fastest CAGR during the forecast period owing to the growing advancement in imaging technologies utilized for lung cancer diagnosis, rise in the number of smokers, and increase in lung cancer cases.

By end-user, hospital was the highest revenue-grossing segment in the global respiratory disease testing market in 2023 owing to the increasing adoption and utilization of sophisticated respiratory diagnostic equipment such as X-ray machines & respiratory measurement instruments such as spirometers, pulse oximeters, & non-invasive ventilators, growing number of patients diagnosed with lung cancer, rising preference for hospital care, and expanding introduction of advanced medical systems. For instance, in July 2022, FUJIFILM Healthcare Corporation has introduced the FDR Cross, a versatile hybrid c-arm and portable x-ray solution designed for hospitals and ambulatory surgery centers (ASCs). This Two-in-One Fluoroscopy and Digital Radiography System enables wireless x-ray imaging similar to standard portable x-rays, accommodating various examinations such as table-top, cross-table, wheelchair, and standing chest exams by offsetting the x-ray tube from the built-in detector. Additionally, physician’s clinic is predicted to grow at the fastest CAGR during the forecast period owing to the rise in hospital-acquired infections has led patients to choose physician clinics for respiratory disease diagnosis. Physicians now favor in-house testing options over sending patients to external laboratories. This shift is expected to drive growth in this segment due to the convenience and personalized care offered by physician clinics.

North America region is anticipated for the highest revenue share during the forecast period owing to the increasing occurrence of respiratory conditions such as COPD, asthma, & various respiratory infections, rising demand for portable devices such as advanced spirometers & non-invasive ventilators, and increasing number of approvals granted by regulatory agencies. For instance, in June 2022, BD (Becton, Dickinson, and Company) has secured CE marking for its BD MAX Respiratory Viral Panel (RVP), an innovative molecular diagnostic assay that integrates screening for SARS-CoV-2, Influenza A + B, and Respiratory Syncytial Virus (RSV). This test requires only one nasal swab or nasopharyngeal swab sample to detect whether a patient is positive for COVID-19, influenza, or RSV. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the enhancements in healthcare infrastructure, heightened patient awareness of available diagnostic procedures, an uptick in respiratory disease prevalence, increased investments by industry players, and a surge in product introductions. For instance, in April 2023, QIAGEN has revealed plans to make its QIAstat-Dx syndromic testing solution accessible in Japan soon, featuring a SARS-CoV-2 Respiratory Panel capable of identifying over 20 pathogens from a single patient sample.

This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.

Report Scope:

  • Base Year: 2023
  • Forecast Period: 2024-2034
  • Study Coverage
  • Market Forecast by Product, Application, and End-user
  • Market Forecast for 5 Regions and 17+ Countries
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
  • Exhaustive Company Profiles of Top 10+ Major Market Players

Segmentation: Respiratory Disease Testing Market Report 2023 - 2034

Respiratory Disease Testing Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)

  • Respiratory Measurement Devices
  • Blood Gas Test
  • Imaging Tests
  • Others

Respiratory Disease Testing Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)

  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Tuberculosis
  • Lung Cancer
  • Other

Respiratory Disease Testing Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)

  • Clinical Laboratories
  • Hospital
  • Physicians Clinic
  • Other

Respiratory Disease Testing Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Respiratory Disease Testing Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Respiratory Disease Testing Market: Product Estimates & Trend Analysis
7.1. Product Segment Opportunity Analysis
7.2. Respiratory Measurement Devices
7.2.1. Respiratory Measurement Devices Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Blood Gas Test
7.3.1. Blood Gas Test Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. Imaging Tests
7.4.1. Imaging Tests Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.5. Others
7.5.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Respiratory Disease Testing Market: Application Estimates & Trend Analysis
8.1. Application Segment Opportunity Analysis
8.2. Chronic Obstructive Pulmonary Disease
8.2.1. Chronic Obstructive Pulmonary Disease Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Asthma
8.3.1. Asthma Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Tuberculosis
8.4.1. Tuberculosis Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.5. Lung Cancer
8.5.1. Lung Cancer Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.6. Others
8.6.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Respiratory Disease Testing Market: End-user Estimates & Trend Analysis
9.1. End-user Segment Opportunity Analysis
9.2. Clinical Laboratories
9.2.1. Clinical Laboratories Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Hospital
9.3.1. Hospital Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. Physicians Clinic
9.4.1. Physicians Clinic Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.5. Others
9.5.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Regional Market Analysis
10.1. Regional Market Opportunity Analysis
11. North America Respiratory Disease Testing Market
11.1. North America Respiratory Disease Testing Market
11.1.1. North America Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. North America Respiratory Disease Testing Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. North America Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
11.1.4. North America Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
11.1.5. North America Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.2. U.S. Global Respiratory Disease Testing Market
11.2.1. U.S. Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. U.S. Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
11.2.3. U.S. Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
11.2.4. U.S. Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.3. Canada Global Respiratory Disease Testing Market
11.3.1. Canada Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. Canada Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
11.3.3. Canada Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
11.3.4. Canada Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12. Europe Global Respiratory Disease Testing Market
12.1. Europe Global Respiratory Disease Testing Market
12.1.1. Europe Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Europe Respiratory Disease Testing Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Europe Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
12.1.4. Europe Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.1.5. Europe Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.2. Germany Global Respiratory Disease Testing Market
12.2.1. Germany Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Germany Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
12.2.3. Germany Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.2.4. Germany Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.3. UK Global Respiratory Disease Testing Market
12.3.1. UK Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. UK Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
12.3.3. UK Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.3.4. UK Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.4. France Global Respiratory Disease Testing Market
12.4.1. France Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. France Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
12.4.3. France Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.4.4. France Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.5. Spain Global Respiratory Disease Testing Market
12.5.1. Spain Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. Spain Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
12.5.3. Spain Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.5.4. Spain Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.6. Italy Global Respiratory Disease Testing Market
12.6.1. Italy Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Italy Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
12.6.3. Italy Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.6.4. Italy Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.7. Rest of Europe Global Respiratory Disease Testing Market
12.7.1. Rest of Europe Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Europe Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Europe Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.7.4. Rest of Europe Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13. Asia Pacific Global Respiratory Disease Testing Market
13.1. Asia Pacific Global Respiratory Disease Testing Market
13.1.1. Asia Pacific Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Asia Pacific Respiratory Disease Testing Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Asia Pacific Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
13.1.4. Asia Pacific Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.1.5. Asia Pacific Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.2. Japan Global Respiratory Disease Testing Market
13.2.1. Japan Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Japan Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
13.2.3. Japan Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.2.4. Japan Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.3. China Global Respiratory Disease Testing Market
13.3.1. China Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. China Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
13.3.3. China Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.3.4. China Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.4. India Global Respiratory Disease Testing Market
13.4.1. India Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. India Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
13.4.3. India Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.4.4. India Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.5. South Korea Global Respiratory Disease Testing Market
13.5.1. South Korea Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. South Korea Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
13.5.3. South Korea Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.5.4. South Korea Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.6. Australia Global Respiratory Disease Testing Market
13.6.1. Australia Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.6.2. Australia Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
13.6.3. Australia Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.6.4. Australia Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.7. Rest of Asia Pacific Global Respiratory Disease Testing Market
13.7.1. Rest of Asia Pacific Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.7.2. Rest of Asia Pacific Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
13.7.3. Rest of Asia Pacific Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.7.4. Rest of Asia Pacific Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14. Latin America Global Respiratory Disease Testing Market
14.1. Latin America Global Respiratory Disease Testing Market
14.1.1. Latin America Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Latin America Respiratory Disease Testing Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Latin America Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
14.1.4. Latin America Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.1.5. Latin America Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.2. Brazil Global Respiratory Disease Testing Market
14.2.1. Brazil Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Brazil Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
14.2.3. Brazil Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.2.4. Brazil Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.3. Mexico Global Respiratory Disease Testing Market
14.3.1. Mexico Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. Mexico Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
14.3.3. Mexico Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.3.4. Mexico Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.4. Argentina Global Respiratory Disease Testing Market
14.4.1. Argentina Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Argentina Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
14.4.3. Argentina Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.4.4. Argentina Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.5. Rest of Latin America Global Respiratory Disease Testing Market
14.5.1. Rest of Latin America Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. Rest of Latin America Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
14.5.3. Rest of Latin America Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.5.4. Rest of Latin America Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15. MEA Global Respiratory Disease Testing Market
15.1. MEA Global Respiratory Disease Testing Market
15.1.1. MEA Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. MEA Respiratory Disease Testing Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. MEA Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
15.1.4. MEA Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.1.5. MEA Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.2. GCC Global Respiratory Disease Testing Market
15.2.1. GCC Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. GCC Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
15.2.3. GCC Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.2.4. GCC Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.3. South Africa Global Respiratory Disease Testing Market
15.3.1. South Africa Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. South Africa Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
15.3.3. South Africa Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.3.4. South Africa Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15.4. Rest of MEA Global Respiratory Disease Testing Market
15.4.1. Rest of MEA Respiratory Disease Testing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. Rest of MEA Respiratory Disease Testing Market Size and Forecast, By Product, 2023-2034 (Revenue USD Bn)
15.4.3. Rest of MEA Respiratory Disease Testing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.4.4. Rest of MEA Respiratory Disease Testing Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
16. Competitor Analysis
16.1. Company Market Share Analysis, 2023
16.2. Major Recent Developments
17. Company Profiles
17.1. BIOMÉRIEUX
17.2. Medtronic
17.3. Koninklijke Philips N.V.
17.4. ResMed
17.5. Siemens Healthcare GmbH
17.6. BD
17.7. Carestream Health
17.8. Abbott
17.9. SDI Diagnostics
17.10. Fisher & Paykel Appliances Ltd.
17.11. Other Prominent Players
18. Conclusion19. Recommendations

Companies Mentioned

  • BIOMÉRIEUX
  • Medtronic
  • Koninklijke Philips N.V.
  • ResMed
  • Siemens Healthcare GmbH
  • BD
  • Carestream Health
  • Abbott
  • SDI Diagnostics
  • Fisher & Paykel Appliances Ltd.